Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the BrasMEN study

Imagem de Miniatura
Arquivos
art_MACIEL_Genotype_and_phenotype_landscape_of_MEN2_in_554_2019.PDF (717.62 KB)
Citações na Scopus
24
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOSCIENTIFICA LTD
Autores
MACIEL, Rui M. B.
CAMACHO, Cleber P.
ASSUMPCAO, Ligia V. M.
BUFALO, Natassia E.
CARVALHO, Andre L.
CARVALHO, Gisah A. de
JR, Francisco M. de Castro
CEOLIN, Lucieli
CERUTTI, Janete M.
Citação
ENDOCRINE CONNECTIONS, v.8, n.3, p.289-298, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant genetic disease caused by RET gene germline mutations that is characterized by medullary thyroid carcinoma (MTC) associated with other endocrine tumors. Several reports have demonstrated that the RET mutation profile may vary according to the geographical area. In this study, we collected clinical and molecular data from 554 patients with surgically confirmed MTC from 176 families with MEN2 in 18 different Brazili an centers to compare the type and prevalence of RET mutations with those from other countries. The most frequent mutations, classified by the number of families affected, occur in codon 634, exon 11 (76 families), followed by codon 918, exon 16 (34 families: 26 with M918T and 8 with M918V) and codon 804, exon 14 (22 families: 15 with V804M and 7 with V804L). When compared with other major published series from Europe, there are several similarities and some differences. While the mutations in codons C618, C620, C630, E768 and S891 present a similar prevalence, some mutations have a lower prevalence in Brazil, and others are found mainly in Brazil (G533C and M918V). These results reflect the singular proportion of European, Amerindian and African ancestries in the Brazilian mosaic genome.
Palavras-chave
RET, Brazil, multiple endocrine neoplasia, medullary thyroid carcinoma, pheochromocytoma
URI
https://observatorio.fm.usp.br/handle/OPI/31618
Referências
  1. Bethanis Sotirios, 2007, Hormones (Athens), V6, P152
  2. Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658
  3. Braudel F, 1995, MEDITERRANEAN MEDITE
  4. Camacho CP, 2008, ARQ BRAS ENDOCRINOL, V52, P1393, DOI 10.1590/S0004-27302008000800031
  5. CARLSON KM, 1994, P NATL ACAD SCI USA, V91, P1579, DOI 10.1073/pnas.91.4.1579
  6. Casey R, 2013, ENDOCRINOL DIAB META, DOI 10.1530/EDM-13-0044
  7. Castinetti F, 2017, ENDOCR-RELAT CANCER, V24, pL63, DOI 10.1530/ERC-17-0189
  8. Castro MR, 2013, THYROID, V23, P1547, DOI 10.1089/thy.2012.0599
  9. Cerutti JM, 2013, CLIN ENDOCRINOL, V79, P591, DOI 10.1111/cen.12155
  10. Cirafici AM, 1997, ENDOCRINOLOGY, V138, P1450, DOI 10.1210/en.138.4.1450
  11. Cosci B, 2011, ENDOCR-RELAT CANCER, V18, P603, DOI 10.1530/ERC-11-0117
  12. Cunha LL, 2017, EUR J ENDOCRINOL, V176, P515, DOI 10.1530/EJE-16-1021
  13. Da Silva AMA, 2003, J CLIN ENDOCR METAB, V88, P5438, DOI 10.1210/jc.2003-030997
  14. DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851
  15. Edge S, 2010, AJCC CANC STAGING MA
  16. Elisei R, 2012, J CLIN ENDOCR METAB, V97, P426, DOI 10.1210/jc.2011-2046
  17. ENG C, 1994, HUM MOL GENET, V3, P237, DOI 10.1093/hmg/3.2.237
  18. Hoff AO, 2017, ENDOCRINOLOGY PRINCI, P1275
  19. HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0
  20. Kaldrymides P, 2006, CLIN ENDOCRINOL, V64, P561, DOI 10.1111/j.1365-2265.2006.020509.x
  21. Kloos RT, 2009, THYROID, V19, P565, DOI 10.1089/thy.2008.0403
  22. Lebeault M, 2017, THYROID, V27, P1511, DOI 10.1089/thy.2016.0399
  23. Lindsey SC, 2012, HORM CANCER-US, V3, P181, DOI 10.1007/s12672-012-0109-7
  24. Long KL, 2017, FAM CANCER, V16, P283, DOI 10.1007/s10689-016-9948-7
  25. Machens A, 2018, ENDOCR-RELAT CANCER, V25, pL27, DOI 10.1530/ERC-17-0514
  26. Machens A, 2013, EUR J ENDOCRINOL, V168, P307, DOI 10.1530/EJE-12-0919
  27. Machens A, 2009, ANN SURG, V250, P305, DOI 10.1097/SLA.0b013e3181ae333f
  28. Maciel RMB, 2018, ENDOCR-RELAT CANCER, V25, pL49, DOI 10.1530/ERC-17-0349
  29. Maia AL, 2016, GUIDE OF ONCOLOGY
  30. Maia AL, 2014, ARQ BRAS ENDOCRINOL, V58, P667, DOI 10.1590/0004-2730000003427
  31. Martins-Costa MC, 2016, ENDOCR-RELAT CANCER, V23, P909, DOI 10.1530/ERC-16-0141
  32. Mathiesen JS, 2017, THYROID, V27, P215, DOI 10.1089/thy.2016.0411
  33. MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0
  34. Mulligan LM, 2014, NAT REV CANCER, V14, P173, DOI 10.1038/nrc3680
  35. Niccoli-Sire P, 2001, J CLIN ENDOCR METAB, V86, P3746, DOI 10.1210/jc.86.8.3746
  36. Opsahl EM, 2016, THYROID, V26, P1225, DOI 10.1089/thy.2015.0673
  37. Pena SDJ, 2009, BRAZ J MED BIOL RES, V42, P870, DOI 10.1590/S0100-879X2009005000026
  38. Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063
  39. Peppa M, 2008, EUR J ENDOCRINOL, V159, P767, DOI 10.1530/EJE-08-0476
  40. Magalhaes PKR, 2011, THYROID, V21, P547, DOI 10.1089/thy.2010.0336
  41. Romei C, 2015, CLIN ENDOCRINOL, V82, P892, DOI 10.1111/cen.12686
  42. Romei C, 2010, EUR J ENDOCRINOL, V163, P301, DOI 10.1530/EJE-10-0333
  43. Sarika HL, 2012, CLIN ENDOCRINOL, V77, P857, DOI 10.1111/j.1365-2265.2012.04462.x
  44. Sarika HL, 2015, EUR J ENDOCRINOL, V172, P501, DOI 10.1530/EJE-14-0817
  45. Signorini PS, 2014, CLIN ENDOCRINOL, V80, P235, DOI 10.1111/cen.12264
  46. Siqueira DR, 2010, ENDOCR-RELAT CANCER, V17, P953, DOI 10.1677/ERC-09-0312
  47. Toledo RA, 2015, ARCH ENDOCRIN METAB, V59, P476, DOI 10.1590/2359-3997000000060
  48. Toledo RA, 2015, ENDOCR-RELAT CANCER, V22, P65, DOI 10.1530/ERC-14-0491
  49. Toledo RA, 2010, J CLIN ENDOCR METAB, V95, P1318, DOI 10.1210/jc.2009-1355
  50. Valente FOF, 2013, J ENDOCRINOL INVEST, V36, P975, DOI 10.3275/8997
  51. Voss RK, 2017, J CLIN ENDOCR METAB, V102, P2807, DOI 10.1210/jc.2017-00317
  52. Wells SA, 2015, THYROID, V25, P567, DOI 10.1089/thy.2014.0335

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/25
Artigos e Materiais de Revistas Científicas - ODS/03